Survival time of HIV-infected patients with cryptococcal meningitis

Journal of the Medical Association of Thailand

Volumn 90, Issue 10, 2007, Pages 2104-2111

  Chottanapund, Suthat ^a,b   Singhasivanon, Pratap ^a   Kaewkungwal, Jaranit ^a   Chamroonswasdi, Kanittha ^a   Manosuthi, Weerawat ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Antiretroviral therapy; Cryptococcal meningitis; GPO VIR; HIV AIDS; Survival time

Indexed keywords

AMPHOTERICIN B; ANTIRETROVIRUS AGENT; FLUCONAZOLE; GPO VIR; NEVIRAPINE; UNCLASSIFIED DRUG;

ADULT; ANTIBIOTIC THERAPY; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OPPORTUNISTIC INFECTION; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; REVIEW; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION;

ADULT; AMPHOTERICIN B; ANTI-BACTERIAL AGENTS; CD4 LYMPHOCYTE COUNT; COMORBIDITY; FEMALE; FLUCONAZOLE; HIV INFECTIONS; HUMANS; MALE; MENINGITIS, CRYPTOCOCCAL; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL; TIME FACTORS;

EID: 35848947740     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Holmes CB, Losina E, Walensky RP, Yazdanpanah Y, Freedberg KA. Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa. Clin Infect Dis 2003; 36: 652-62.
2. Chariyalertsak S, Sirisanthana T, Saengwonloey O, Nelson KE. Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994-1998: regional variation and temporal trends. Clin Infect Dis 2001; 32: 955-62.
3. HIV/AIDS situation in Thailand by August 2003. Bangkok: AIDS Cluster, Bureau of AIDS, TB and STIs, Department of Diseases Control, Ministry of Public Health; 2006.
4. HIV/AIDS situation in Thailand. Bangkok: Bureau of epidemiology, Department of Diseases Control, Ministry of Public Health; 2006.
5. Powderly W. Cryptococcosis. New York: Churchill Livingstone; 1999.
6. Mirza SA, Phelan M, Rimland D, Graviss E, Hamill R, Brandt ME, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003; 36: 789-94.
7. Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis 2000; 30: 710-8.
8. van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med 1997; 337: 15-21.
9. Pitisuttithum P, Tansuphasawadikul S, Simpson AJ, Howe PA, White NJ. A prospective study of AIDS-associated cryptococcal meningitis in Thailand treated with high-dose amphotericin B. J Infect 2001; 43: 226-33.
10. Larsen RA, Leal MA, Chan LS. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial. Ann Intern Med. 1990; 113: 183-7.
11. Robinson PA, Bauer M, Leal MA, Evans SG, Holtom PD, Diamond DA, et al. Early mycological treatment failure in AIDS-associated cryptococcal meningitis. Clin Infect Dis 1999; 28: 82-92.
12. Saag MS, Cloud GA, Graybill JR, Sobel JD, Tuazon CU, Johnson PC, et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group. Clin Infect Dis 1999; 28: 291-6.
13. Imwidthaya P, Poungvarin N. Cryptococcosis in AIDS. Postgrad Med J 2000; 76: 85-8.
14. Jenkins P. Survival analysis [Unpublished manuscript]. Colchester, UK: Institute for Social and Economic Research, University of Essex; 2005.
15. Kleinbaum D. Survival analysis: a self-learning text. New York: Springer; 1996.
16. Miller RG Jr. Survival analysis. New York: Wiley; 1981.
17. Klein JP, Moeschberger ML. Survival analysis. Techniques for censored & truncated data. New York: Springer-Verlag; 1997.
18. Stata Statistical Software: Release 7.0. Collage Station, TX: Stata Corporation; 2001.
19. Carretero G, Aguado G, Llano A. Cryptococcosis in AIDS patients: a study of 19 cases. Rev Clin Esp 1992; 190: 450-4.
20. Darras-Joly C, Chevret S, Wolff M, Matheron S, Longuet P, Casalino E, et al. Cryptococcus neoformans infection in France: epidemiologic features of and early prognostic parameters for 76 patients who were infected with human immunodeficiency virus. Clin Infect Dis 1996; 23: 369-76.
21. Knudsen JD, Jensen L, Sorensen TL, Jensen T, Kjersem H, Stenderup J, et al. Cryptococcosis in Denmark: an analysis of 28 cases in 1988-1993. Scand J Infect Dis 1997; 29: 51-5.
22. Mwaba P, Mwansa J, Chintu C, Pobee J, Scarborough M, Portsmouth S, et al. Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions. Postgrad Med J 2001; 77: 769-73.
23. Oursler KA, Moore RD, Chaisson RE. Risk factors for cryptococcal meningitis in HIV-infected patients. AIDS Res Hum Retroviruses 1999; 15: 625-31.
24. Graybill JR, Sobel J, Saag M, van Der HC, Powderly W, Cloud G, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 2000; 30: 47-54.
25. Inverarity D, Bradshaw Q, Wright P, Grant A. The spectrum of HIV-related disease in rural Central Thailand. Southeast Asian J Trop Med Public Health 2002; 33: 822-31.
26. Chetchotisakd P, Sungkanuparph S, Thinkhamrop B, Mootsikapun P, Boonyaprawit P. A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency. HIV Med 2004; 5: 140-3.
27. Lortholary O, Poizat G, Zeller V, Neuville S, Boibieux A, Alvarez M, et al. Long-term outcome of AIDSassociated cryptococcosis in the era of combination antiretroviral therapy. AIDS 2006; 20: 2183-91.